Underrepresentation of women scientists in the public sphere perpetuates the stereotype of the white male scientist and fails both to reflect the true diversity of people practicing science today and to encourage more diversity. In a new article publishing April 23 in the open-access journal PLOS Biology, Dr. Elizabeth McCullagh and colleagues from the grassroots organization 500 Women Scientists, describe the first year of a database they founded in January 2018 to combat this issue.
Bureaucratic quality in developing countries is endangered by the structural adjustment programs imposed by the international financial institutions, a paper by Bocconi's Alexander Kentikelenis and colleagues, in the American Journal of Sociology, states. In particular, the IMF's structural reforms mandating privatization, price deregulation, and reductions in public sector employment jeopardize state capacity by compromising the healthy relationship between state and business, as in uncertain times bureaucrats are more likely to fall prey to private interests.
Firms that value and practice environmental transparency in their reporting to stakeholders are in general better economic performers than those whose practices are more opaque.
A new paper in the European Sociological Review indicates that women's and men's earnings are not affected by the share of female managers in an organization, nor by the sex of workers' individual managers.
Pancreatic Cancer Collective-funded research (Lustgarten Foundation and Stand Up To Cancer) from Dr. Tony Hunter (Salk Institute) and the SU2C-CRUK-Lustgarten Pancreatic Cancer Dream Team has found the presence of a key protein (Leukemia Inhibitory Factor or LIF) in PDAC microenvironment may be an exploitable treatment target to slow tumor progression or metastasis and may lead to the development of new targeted strategies for pancreatic cancer therapy.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging. The workshop was co-sponsored by NIH, the Radiological Society of North America (RSNA), the American College of Radiology (ACR) and The Academy for Radiology and Biomedical Imaging Research (The Academy). The organizers aimed to foster collaboration in applications for diagnostic medical imaging, identify knowledge gaps and develop a roadmap to prioritize research needs.
The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Therapeutic Area Standard that specifies how to structure commonly collected data and outcome measurements in clinical trials for HIV. The standard, released in the form of User Guide for data managers, statisticians, programmers and study managers, covers the areas of prevention, vaccines and treatment and is freely available on the CDISC website.
Atomwise Inc., a biotech company using artificial intelligence (AI) for drug discovery, and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development organization working to deliver new treatments for neglected diseases, today announced that promising drug-like compounds have been discovered in a program to develop first-in-class treatments for Chagas disease. The research collaboration is part of Atomwise's Artificial Intelligence Molecular Screen (AIMS) Awards program.
Gjergji Cici of the KU School of Business co-authored a study that is among the first to see how noncompete clauses influence those work under them, instead of the debate about their role in economic development or profits.
Dangers of policing have dramatically declined since 1970 with a 75 percent drop in police officer line-of-duty deaths. In the context of nearly 50-year monthly trends, the study also shows a statistically significant decline in felonious killings of police following the Ferguson effect and Michael Brown's death in 2014, which directly contradicts the war on cops' theory.